Pfizer Unveils $1 Billion Manufacturing Facility in Tuas Biomedical Park

Pfizer Unveils $1 Billion Manufacturing Facility in Tuas Biomedical Park

23 Jul, 2024

 Pfizer Unveils $1 Billion Manufacturing Facility in Tuas Biomedical Park

Pfizer has opened a new $1 billion Active Pharmaceutical Ingredient (API) manufacturing facility in Tuas Biomedical Park, Singapore. The 429,000 sq ft facility will produce small molecule APIs for oncology, pain, and antibiotic medicines, creating over 250 jobs. Designed for future expansions, it includes processing suites, a warehouse, and energy-efficient technologies. The facility holds a Green Mark Gold certification, underscoring Pfizer's commitment to sustainability.

Related News

Grab Partners with London School of Business for Education Programmes

08 Jan, 2025

Grab has partnered with the London School of Business and…
Read More
Singapore Tech Start-ups Expanding Presence in the US, Reports SBF

02 Jan, 2025

Many local tech start-ups in Singapore are looking to expand…
Read More
Atome, Valiram Partner for Flexible Financial Services in Malaysia, Singapore

05 Dec, 2024

Atome, a leading financial services platform, has partnered with Valiram,…
Read More
HSBC Report Names Singapore Hong Kong Top Asian Markets for Investment

28 Nov, 2024

According to a recent HSBC report, Singapore and Hong Kong…
Read More
Despite Hype Only 27% of Singapore Businesses Have Adopted AI

20 Nov, 2024

A recent HubSpot report reveals that despite Singapore’s growing focus…
Read More
CM Mohan Charan Majhi urges Singapore leaders to explore Odisha

18 Nov, 2024

Chief Minister Mohan Charan Majhi on Sunday urged investors and…
Read More

Interview

© 2025 Business International News. All rights reserved | Powered by Cred Matters.